Impact of surgical resection on survival in patients with metastatic soft tissue sarcoma and comparison between synchronous and metachronous metastases

被引:2
|
作者
Outani, Hidetatsu [1 ]
Hamada, Kenichiro [1 ]
Yasuda, Naohiro [1 ]
Ueda, Takafumi [2 ]
Myoui, Akira [1 ]
Yoshikawa, Hideki [1 ,3 ]
Okada, Seiji [1 ]
机构
[1] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, 2-2Yamadaoka, Suita, Osaka 5650871, Japan
[2] Kodama Hosp, Dept Orthopaed Surg, I-3-2 Gotenyama, Takarazuka, Hyogo 5418567, Japan
[3] Toyonaka City Hosp, Dept Orthopaed Surg, 4-14-1 Shibaharacho, Toyonaka, Osaka 5608565, Japan
基金
日本学术振兴会;
关键词
ADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; PULMONARY METASTASECTOMY; EXTREMITY; DISEASE; TUMORS;
D O I
10.1016/j.jos.2021.03.013
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: The role of local surgery in patients with metastatic soft tissue sarcoma (STS) remains unknown. The study aims to assess the clinical outcomes and impact of surgical resection on survival in patients with metastatic STS and elucidate the survival differences between synchronous and metachronous metastatic groups. Methods: Among the 272 patients with STS treated between 2000 and 2018, 84 with synchronous or metachronous metastasis were included. Associations between overall survival and primary tumor resection and metastasectomy were assessed using multivariate Cox regression analyses to adjust for baseline differences between surgically and non-surgically treated patients. Propensity score matching was applied to compare synchronous and metachronous metastasis. Results: Among the 84 patients included, 69 (82%) and 41 (49%) underwent primary tumor resection and metastasectomy, respectively. The 2- and 5-year overall survivals of all patients after first detection of metastasis were 51.1% and 24.4%, respectively. Multivariate analysis showed that size <8 cm, grade <3, and number of metastases <4 were associated with longer overall survival. After adjusting for baseline demographic and tumor characteristics, primary tumor resection and metastasectomy still had favorable effects on survival. Tumor subtypes, grade, and number of metastases differed significantly between synchronous and metachronous groups. However, after adjusting for these valuables, both groups exhibited comparable survival. Conclusions: Approximately one fourth of the patients with metastatic STS survived for >5 years. Our results showed that surgical resection of primary tumors or metastatic lesions had favorable impact on survival even after adjusting for patient backgrounds, with comparable survival observed between those with synchronous and metachronous metastases. (C) 2021 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:892 / 898
页数:7
相关论文
共 50 条
  • [31] Colorectal Cancer Survival: An Analysis of Patients With Metastatic Disease Synchronous and Metachronous With the Primary Tumor
    Kumar, Rajiv
    Price, Timothy J.
    Beeke, Carol
    Jain, Kunal
    Patel, Gargi
    Padbury, Rob
    Young, Graeme P.
    Roder, David
    Townsend, Amanda
    Bishnoi, Sarwan
    Karapetis, Christos S.
    CLINICAL COLORECTAL CANCER, 2014, 13 (02) : 87 - 93
  • [32] Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity - A retrospective analysis
    Canter, Robert J.
    Qin, Li-Xuan
    Downey, Robert J.
    Brennan, Murray F.
    Singer, Samuel
    Maki, Robert G.
    CANCER, 2007, 110 (09) : 2050 - 2060
  • [33] Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients
    Lahat, G.
    Dhuka, A. R.
    Lahat, S.
    Lazar, A. J.
    Lewis, V. O.
    Lin, P. P.
    Feig, B.
    Cormier, J. N.
    Hunt, K. K.
    Pisters, P. W. T.
    Pollock, R. E.
    Lev, D.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (09) : 2579 - 2586
  • [34] Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups
    Durnali, Ayse Gok
    Turkoz, Fatma Paksoy
    Yukruk, Fisun Ardic
    Tokluoglu, Saadet
    Yazici, Omer Kamil
    Demirci, Ayse
    Bal, Oznur
    Buyukbas, Selay Gundogdu
    Esbah, Onur
    Oksuzoglu, Berna
    Alkis, Necati
    PLOS ONE, 2016, 11 (05):
  • [35] The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma
    Nakamura, Tomoki
    Matsumine, Akihiko
    Asanuma, Kunihiro
    Matsubara, Takao
    Sudo, Akihiro
    TUMOR BIOLOGY, 2015, 36 (10) : 7515 - 7520
  • [36] Impact of unplanned resection and re-excision of a soft tissue sarcoma on prognosis
    Munoz Munoz, Paula
    Bajawi Carretero, Mariam
    Gonzalez Barranquero, Alberto
    Mena Mateos, Antonio
    Corral Moreno, Sara
    Sanjuanbenito Dehesa, Alfonso
    Cabanas Montero, Jacobo
    Lobo Martinez, Eduardo
    CIRUGIA ESPANOLA, 2020, 98 (05): : 281 - 287
  • [37] Monitoring the Adequacy of Surgical Margins After Resection of Bone and Soft-Tissue Sarcoma
    Biau, David J.
    Weiss, Kurt R.
    Bhumbra, Rej S.
    Davidson, Darin
    Brown, Chris
    Griffin, Anthony
    Wunder, Jay S.
    Ferguson, Peter C.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (06) : 1858 - 1864
  • [38] Durable Responses to Chemotherapy in Patients with Metastatic Soft-Tissue Sarcoma
    Wessels, Tim
    Rogiers, Aljosja
    Schoffski, Patrick
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (10) : 618 - 621
  • [39] Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years
    Lochner, Jakob
    Menge, Franka
    Vassos, Nikolaos
    Hohenberger, Peter
    Kasper, Bernd
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (11) : 613 - 619
  • [40] Multimodality Management of Metastatic Patients With Soft Tissue Sarcomas May Prolong Survival
    Bedi, Meena
    King, David M.
    Charlson, John
    Whitfield, Robert
    Hackbarth, Donald A.
    Zambrano, Eduardo V.
    Wang, Dian
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (03): : 272 - 277